Literature DB >> 6660596

Population studies on the ELA system in American standardbred and thoroughbred mares.

E Bailey.   

Abstract

336 Standardbred mares and 334 Thoroughbred mares in the vicinity of Lexington, Kentucky, were lymphocyte typed for 11 allelic antigenic specificities of the equine lymphocyte antigen (ELA) system. The Standardbred mares were divided into a population of pacers and a population of trotters. Substantial differences in ELA gene frequencies were found between the 3 groups. When the distribution of antigens within populations were compared to Hardy-Weinberg equilibrium expectations, relatively good agreement was found.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6660596     DOI： 10.1111/j.1365-2052.1983.tb01073.x

Source DB:  PubMed          Journal:  Anim Blood Groups Biochem Genet        ISSN： 0003-3480


  10 in total

1.  Linkage studies between the Tcp-1, Tcp-10, and Mhc-Eqca-A loci in the horse.

Authors:  J L Langemeier; E Bailey; P J Henney
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.

Authors:  S A Hammond; S J Cook; D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.

Authors:  Robert H Mealey; Jae-Hyung Lee; Steven R Leib; Matt H Littke; Travis C McGuire
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

4.  Segregation distortion within the equine MHC; analogy to a mouse T/t-complex trait.

Authors:  E Bailey
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Authors:  Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

6.  Analysis of the equine lymphocyte antigen system by Southern blot hybridization.

Authors:  A J Alexander; E Bailey; J G Woodward
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.

Authors:  R H Mealey; D M Stone; M T Hines; D C Alperin; M H Littke; S R Leib; S E Leach; S A Hines
Journal:  Vaccine       Date:  2007-08-15       Impact factor: 3.641

8.  Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.

Authors:  G Allen; M Yeargan; L R Costa; R Cross
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.

Authors:  Robert H Mealey; Steven R Leib; Matt H Littke; Bettina Wagner; David W Horohov; Travis C McGuire
Journal:  Vaccine       Date:  2009-02-24       Impact factor: 3.641

10.  Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.

Authors:  W Zhang; S M Lonning; T C McGuire
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.